Coronary Plaque Volume in an Asymptomatic Population: Miami Heart Study at Baptist Health South Florida

Keishi Ichikawa1, Shai Ronen2, Rachelle Bishay1

  • 1Lundquist Institute, Harbor-UCLA Medical Center, Torrance, California, USA.

PubMed

Insights

Coronary plaque volume is common in asymptomatic adults, increasing with age. AI-QCT analysis revealed significant sex differences in plaque burden, informing normative data for cardiovascular risk assessment.

Area of Science:

  • Cardiovascular Imaging and Diagnostics
  • Quantitative Plaque Analysis
  • Population Health Studies

Background:

  • Coronary computed tomography angiography (CTA)-derived plaque burden is a key predictor of cardiovascular events.
  • Establishing normative values for quantitative plaque volume in the general population is crucial for clinical decision-making.
  • Understanding plaque distribution aids in identifying individuals at higher cardiovascular risk.

Purpose of the Study:

  • To investigate the distribution of coronary plaque volume in a large, community-based asymptomatic cohort.
  • To develop age- and sex-specific nomograms for quantitative plaque volume using artificial intelligence.
  • To provide normative data for plaque burden assessment in the general population.

Main Methods:

  • Quantitative coronary computed tomography angiography (AI-QCT) analysis was performed on 2,301 asymptomatic subjects from the Miami Heart Study (MiHEART).
  • Artificial intelligence was utilized for automated plaque volume quantification.
  • Nonparametric techniques were employed to estimate plaque volume distribution percentiles.

Main Results:

  • The median total plaque volume was 54 mm³ (Q1-Q3: 16-126 mm³), increasing with age.
  • Males exhibited significantly higher median plaque volumes (80 mm³) compared to females (34 mm³; P < 0.001).
  • Plaque prevalence (≥20 mm³) was higher in males (81.5%) than females (61.9%); younger individuals showed more noncalcified plaque.

Conclusions:

  • A substantial majority of asymptomatic individuals in the study cohort had detectable coronary plaque via AI-QCT.
  • Age- and sex-specific nomograms derived from this study offer valuable insights into plaque volume distribution.
  • These findings establish normative data for coronary plaque volume in an asymptomatic population, aiding clinical risk stratification.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System IV: CMRI01:21

Imaging Studies for Cardiovascular System IV: CMRI

Cardiovascular magnetic resonance imaging, or CMRI, is a non-invasive diagnostic test that employs a magnetic field and radiofrequency waves to create precise images of the heart and arteries. It provides comprehensive information about cardiac anatomy, function, perfusion, and tissue characterization without ionizing radiation.IndicationsCMRI diagnoses various heart conditions, including tissue damage from heart attacks, ischemic heart disease, myocarditis, aortic issues (tears, aneurysms,...
541
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
620
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
890
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
495